BodyM
Stay steady on GLP-1s.
Learn by the problem you have now.

Plain GLP-1 guides for side effects, dose changes, food, recovery, and support products.

GLP KeepFit knowledge library

Detailed GLP-1 guidance, organized by real user questions.

This is the structured reference layer for GLP KeepFit. It covers starting fit, drug and brand differences, side-effect timing, symptom-by-symptom solutions, stopping and restarting, and the main GLP support products users already compare.

Pages
1
Clear guides for the questions people ask most often.
Structure
6
Start, dose changes, side effects, food, recovery, and product comparisons.
Best use
Read by problem first.
Pick the question you are facing now, then open the most relevant guide.

Use these pages before the first dose: who usually qualifies, what to check first, and which drug path fits the journey you are actually about to start.

Quick reference

Start Here at a glance

Before-you-start baseline map

LayerWhy it mattersWhat should already be clear
FitThe plan depends on why the user is starting nowGoal, history, prior attempts, affordability
Risk reviewSome issues change whether the first step should even happenPregnancy, pancreatitis, thyroid warning history, severe GI history
Baseline behaviorYou cannot interpret new symptoms if the old pattern is unknownBowel rhythm, meal size, protein, hydration, dizziness, reflux
Start Here10 min readApr 17, 2026

Starting GLP-1: eligibility, contraindications, and baseline checks

A structured before-you-start page covering who typically uses GLP-1s for weight management, what needs prescriber review first, and what a serious support product should capture before day one.

This page includes
  • Who usually fits GLP-1 weight-management treatment and who needs more review first
  • Which contraindications and caution situations should already be known before day one
  • Which baseline GI, intake, and hydration patterns are worth capturing before appetite drops
  • What a companion system should have ready before the first dose window starts
Key data point
3
Foundational layers: fit, risk review, and baseline tracking
start hereeligibilitycontraindications
Read page